Schwazze
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
Schwazze earns a Neutral rating with a 46.3 composite score and low 2/5 conviction. Fundamentals provide the strongest pillar at 56.0, supported by the 64.8 gross-margin subscore, 72.0 operating-margin subscore, and 90.0 cash-runway subscore. Regulatory contributes 49.0, reflecting a balanced jurisdiction posture and an 80.0 enforcement subscore, partly offset by a weak 25.0 filing-cadence result. Market contributes 40.0 because institutional pricing feeds provide no current quote, limiting confirmation from trading performance and valuation signals. Editorial ranks last at 30.0, with no newsroom or briefing activity in CIN newsroom coverage. The resulting profile supports neither a premium rating nor an outright bearish stance.
Licensed fundamentals data show year-over-year revenue growth of approximately 2%, indicating limited top-line momentum. Gross margin approaches 38.9%, providing the clearest operating support within the fundamentals pillar, while the operating margin remains negative at roughly 6.4%. EBITDA stands near $11.2 million, but net income is a loss approaching $59.7 million. That divergence leaves the financial condition stretched; positive EBITDA does not erase bottom-line pressure or establish durable liquidity. Primary regulatory filings show no available latest filing date, while the prior 90-day and 180-day windows contain no recorded regulatory events. No enforcement hits support the stronger enforcement subscore, although the absence of a current filing timestamp constrains visibility and keeps regulatory performance below fundamentals.
The principal forward catalyst rests on fundamentals, where margin conversion can lift the composite more effectively than currently absent market or editorial signals. Gross margin already supplies the strongest reported operating base, and positive EBITDA demonstrates some underlying earnings capacity. A sustained move from modest revenue expansion and negative operating margin toward stronger operating profitability would validate the favorable fundamentals subscores while reducing the tension created by the large net loss. Better filing cadence could improve transparency, but it remains secondary to earnings conversion. The single most important signal to watch is whether gross-margin support translates into a positive operating margin in the next primary regulatory filings.
- IR / PR agency
- Elevate IR
- IR email
- ir@schwazze.com
- IR page
- Investor relations
- CEO
- Forrest Hoffmaster
- SEC CIK
- 0001622879
- Website
- Company website
- Market cap
- $0.0M
- Enterprise value
- $185.8M
- EV / EBITDA
- 13.64
- Revenue (TTM)
- $174.9M
- Gross profit (TTM)
- $68.0M
- EBITDA
- $11.2M
- Operating margin
- -6.3%
- Profit margin
- -34.1%
- Rev growth YoY
- 2.0%
- Return on equity
- -50.0%
- Return on assets
- -1.9%
- EPS (TTM)
- $-0.94
- Wall St. target price
- $1.44
- Shares outstanding
- 80.2M
- Institutional ownership
- 0.5%
- Beta
- 76.15
- Full-time employees
- 729
- GICS sector
- Healthcare
- GICS industry
- Pharmaceutical Retailers
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for Schwazze (SHWZ)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Schwazze (SHWZ), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for SHWZ are maintained by Cannabis Investor News and refreshed throughout the trading day.